Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Chris W. Nyambura"'
Publikováno v:
Polymers, Vol 14, Iss 21, p 4730 (2022)
Protein therapeutics have the potential to treat a wide range of ailments due to the high specificity in their function and their ability to replace missing or mutated genes that encode for key cellular processes. Despite these advantages, protein dr
Externí odkaz:
https://doaj.org/article/00a1745e73a04a07912278ec934ff91f
Autor:
Andrea Joseph, Chris W. Nyambura, Danielle Bondurant, Kylie Corry, Denise Beebout, Thomas R. Wood, Jim Pfaendtner, Elizabeth Nance
Publikováno v:
Pharmaceutics, Vol 13, Iss 8, p 1131 (2021)
Neonatal hypoxic-ischemic encephalopathy is the leading cause of permanent brain injury in term newborns and currently has no cure. Catalase, an antioxidant enzyme, is a promising therapeutic due to its ability to scavenge toxic reactive oxygen speci
Externí odkaz:
https://doaj.org/article/a7ff1e24210240c58ca5acb09e70392a
Publikováno v:
Journal of Applied Polymer Science. 139
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::61fadd689cfc9b31f6115c43f6bc6c14
https://doi.org/10.1002/app.52732
https://doi.org/10.1002/app.52732
Autor:
Denise Beebout, Jim Pfaendtner, Danielle Bondurant, Chris W Nyambura, Elizabeth Nance, Thomas R. Wood, Andrea Joseph, Kylie Corry
Publikováno v:
Pharmaceutics
Volume 13
Issue 8
Pharmaceutics, Vol 13, Iss 1131, p 1131 (2021)
Volume 13
Issue 8
Pharmaceutics, Vol 13, Iss 1131, p 1131 (2021)
Neonatal hypoxic-ischemic encephalopathy is the leading cause of permanent brain injury in term newborns and currently has no cure. Catalase, an antioxidant enzyme, is a promising therapeutic due to its ability to scavenge toxic reactive oxygen speci
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::31f20faf9d3ad17f6494c85f2f870100
https://pubmed.ncbi.nlm.nih.gov/34452092
https://pubmed.ncbi.nlm.nih.gov/34452092